Thank you to our authors, reviewers, Editorial Board & readers for advancing pathology.
@DrMahul@Aparwani_dpath
Explore our most-read reviews & discover why Advances in Anatomic Pathology continues to be a trusted resource for the pathology community: https://t.co/DxMVQmP6d4
@AdvAnatPathol continues to strengthen its scientific impact & global reach. Our latest Publisher Report highlights strong citation performance, growing international readership, sustained interest in authoritative review articles that translate emerging science into practice.
Also featured:
• WHO Classification of Tumors of Bone
• Mesenchymal Tumors of the GI Tract (Non-GIST)
• Renal Hypoplasia
• Lung Cancers Following Neoadjuvant Therapy
• Comprehensive Review of Ovarian Serous Carcinoma
📢Our May 2026 special issue on Advances in Precision Diagnostics is live!
👉https://t.co/t35IHewQel
Check out our featured article on Updates in Digital Pathology - free to access through the end of June!!
Thanks to our guest editor @Aparwani_dpath & editor in chief @DrMahul
🖥️ Digital cytopathology
🌐 Remote diagnostic workflows
⚖️ Ethics, validation & regulation
As digital pathology and AI continue to reshape precision medicine, pathologists remain central to integrating morphology, molecular data, and clinical insight to improve patient care.
#ArticleSpotlight
🧵 Literature on ovarian sex cord–stromal tumors is rapidly evolving.
Check out this comprehensive review synthesizing established knowledge and emerging insights in one essential resource. ⬇️ @md_kyle@DrMahul
https://t.co/8RzVtBzkEx
Ductal Adenocarcinoma of the Prostate: Evolution and Current State
https://t.co/maHJ8KVHA4
Dr. Alessia Cimadamore @AlessiaCim and her team just published this comprehensive review of ductal adenocarcinoma of the prostate in Advanced Anatomic Pathology @AdvAnatPathol. This work highlights the evolving landscape of this uncommon yet clinically significant variant - spanning morphology, molecular features, diagnostic challenges, and clinical implications.
Ductal adenocarcinoma remains a fascinating entity, with distinctive histologic features and often more aggressive behavior, yet increasing molecular evidence supports a shared clonal origin with conventional acinar carcinoma. Continued multidisciplinary collaboration will be essential to refine classification, improve diagnostic accuracy, and guide precision management strategies.
Congratulations to Alessia and her team for putting together this important and timely review for our readers - a truly valuable contribution and resource for the field.
#ArticleSpotlight
🧵 Literature on ovarian sex cord–stromal tumors is rapidly evolving.
Check out this comprehensive review synthesizing established knowledge and emerging insights in one essential resource. ⬇️ @md_kyle@DrMahul
https://t.co/8RzVtBzkEx
2/ 📌 Part II: Pure Sex Cord & Sex Cord–Stromal Tumors
From granulosa cell tumors to Sertoli-Leydig cell tumors, this review unpacks morphologic diversity, immunophenotypes, and hallmark genomic alterations (e.g., FOXL2).
https://t.co/VOSXjJbEaf
Stay tuned to our page for an exclusive sneak peek into articles from this special #GUPath issue co-edited by @rovingatuscap & @DrCristinaMagi.
Until then, explore the special issue articles here: https://t.co/2SlebzD2Iz
@DrMahul
We’re excited to announce that Advances in Anatomic Pathology is now on X! 🎉 Follow us for key developments in anatomic & surgical pathology, curated by globally renowned experts.
@DrMahul@JLHornick@Aparwani_dpath